191 related articles for article (PubMed ID: 29439255)
1. Co-Upregulation of 14-3-3ζ and P-Akt is Associated with Oncogenesis and Recurrence of Hepatocellular Carcinoma.
Tang Y; Wang R; Zhang Y; Lin S; Qiao N; Sun Z; Cheng S; Zhou W
Cell Physiol Biochem; 2018; 45(3):1097-1107. PubMed ID: 29439255
[TBL] [Abstract][Full Text] [Related]
2. 14-3-3ζ up-regulates hypoxia-inducible factor-1α in hepatocellular carcinoma via activation of PI3K/Akt/NF-кB signal transduction pathway.
Tang Y; Lv P; Sun Z; Han L; Luo B; Zhou W
Int J Clin Exp Pathol; 2015; 8(12):15845-53. PubMed ID: 26884855
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α.
Tang Y; Liu S; Li N; Guo W; Shi J; Yu H; Zhang L; Wang K; Liu S; Cheng S
Oncotarget; 2016 Mar; 7(13):15854-67. PubMed ID: 26910835
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Dong J; Zhou W
Cancer Med; 2018 Nov; 7(11):5543-5553. PubMed ID: 30358169
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
Chang RM; Xu JF; Fang F; Yang H; Yang LY
Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
Yu L; Zhang J; Guo X; Li Z; Zhang P
Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
Wang D; Zhang X; Lu Y; Wang X; Zhu L
Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma.
Li XP; Yang XY; Biskup E; Zhou J; Li HL; Wu YF; Chen ML; Xu F
Oncotarget; 2015 Sep; 6(26):22880-9. PubMed ID: 26078356
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
[TBL] [Abstract][Full Text] [Related]
10. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
[TBL] [Abstract][Full Text] [Related]
11. Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway.
Ni Q; Chen Z; Zheng Q; Xie D; Li JJ; Cheng S; Ma X
Cancer Sci; 2020 May; 111(5):1500-1513. PubMed ID: 31997489
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway.
Yao B; Li Y; Chen T; Niu Y; Wang Y; Yang Y; Wei X; Liu Q; Tu K
Clin Transl Med; 2021 Mar; 11(3):e366. PubMed ID: 33784016
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
15. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
16. 14-3-3β Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-κB Pathway.
Tang Y; Lv P; Sun Z; Han L; Zhou W
PLoS One; 2016; 11(1):e0146070. PubMed ID: 26730736
[TBL] [Abstract][Full Text] [Related]
17. Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/Bcl-2/BAX pathway.
Sui Y; Zheng X; Zhao D
Tumour Biol; 2015 Nov; 36(11):8661-70. PubMed ID: 26044564
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
19. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
20. Activation of PI3 kinase/Akt/HIF-1α pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma.
Jiao M; Nan KJ
Int J Oncol; 2012 Feb; 40(2):461-8. PubMed ID: 21922131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]